134 related articles for article (PubMed ID: 38740982)
1. FBXO11 variants are associated with intellectual disability and variable clinical manifestation in Chinese affected individuals.
Pan X; Liu L; Zhang X; Tang X; Qian G; Qiu H; Lin S; Yao H; Dong X; Tan B
J Hum Genet; 2024 May; ():. PubMed ID: 38740982
[TBL] [Abstract][Full Text] [Related]
2. The first familial case of inherited intellectual developmental disorder with dysmorphic facies and behavioral abnormalities (IDDFBA) with a novel FBXO11 variant.
Lee CG; Seol CA; Ki CS
Am J Med Genet A; 2020 Nov; 182(11):2788-2792. PubMed ID: 32902151
[TBL] [Abstract][Full Text] [Related]
3. De Novo Variants in the F-Box Protein FBXO11 in 20 Individuals with a Variable Neurodevelopmental Disorder.
Gregor A; Sadleir LG; Asadollahi R; Azzarello-Burri S; Battaglia A; Ousager LB; Boonsawat P; Bruel AL; Buchert R; Calpena E; Cogné B; Dallapiccola B; Distelmaier F; Elmslie F; Faivre L; Haack TB; Harrison V; Henderson A; Hunt D; Isidor B; Joset P; Kumada S; Lachmeijer AMA; Lees M; Lynch SA; Martinez F; Matsumoto N; McDougall C; Mefford HC; Miyake N; Myers CT; Moutton S; Nesbitt A; Novelli A; Orellana C; Rauch A; Rosello M; Saida K; Santani AB; Sarkar A; Scheffer IE; Shinawi M; Steindl K; Symonds JD; Zackai EH; ; ; Reis A; Sticht H; Zweier C
Am J Hum Genet; 2018 Aug; 103(2):305-316. PubMed ID: 30057029
[TBL] [Abstract][Full Text] [Related]
4. De novo variants in FBXO11 cause a syndromic form of intellectual disability with behavioral problems and dysmorphisms.
Jansen S; van der Werf IM; Innes AM; Afenjar A; Agrawal PB; Anderson IJ; Atwal PS; van Binsbergen E; van den Boogaard MJ; Castiglia L; Coban-Akdemir ZH; van Dijck A; Doummar D; van Eerde AM; van Essen AJ; van Gassen KL; Guillen Sacoto MJ; van Haelst MM; Iossifov I; Jackson JL; Judd E; Kaiwar C; Keren B; Klee EW; Klein Wassink-Ruiter JS; Meuwissen ME; Monaghan KG; de Munnik SA; Nava C; Ockeloen CW; Pettinato R; Racher H; Rinne T; Romano C; Sanders VR; Schnur RE; Smeets EJ; Stegmann APA; Stray-Pedersen A; Sweetser DA; Terhal PA; Tveten K; VanNoy GE; de Vries PF; Waxler JL; Willing M; Pfundt R; Veltman JA; Kooy RF; Vissers LELM; de Vries BBA
Eur J Hum Genet; 2019 May; 27(5):738-746. PubMed ID: 30679813
[TBL] [Abstract][Full Text] [Related]
5. De novo FBXO11 mutations are associated with intellectual disability and behavioural anomalies.
Fritzen D; Kuechler A; Grimmel M; Becker J; Peters S; Sturm M; Hundertmark H; Schmidt A; Kreiß M; Strom TM; Wieczorek D; Haack TB; Beck-Wödl S; Cremer K; Engels H
Hum Genet; 2018 May; 137(5):401-411. PubMed ID: 29796876
[TBL] [Abstract][Full Text] [Related]
6. A novel variant in NSUN2 causes intellectual disability in a Chinese family.
Yang Q; Zhang Q; Qin Z; Yi S; Luo J
BMC Med Genomics; 2024 Apr; 17(1):95. PubMed ID: 38643142
[TBL] [Abstract][Full Text] [Related]
7. Case Report: Chinese female patients with a heterozygous pathogenic
Cong Y; Jin H; Wu K; Wang H; Wang D
Front Genet; 2022; 13():900226. PubMed ID: 36046249
[No Abstract] [Full Text] [Related]
8. New ocular findings in a patient with a novel pathogenic variant in the FBXO11 gene.
Silva RG; Dupont J; Silva E; Sousa AB
J AAPOS; 2022 Oct; 26(5):268-270. PubMed ID: 35940561
[TBL] [Abstract][Full Text] [Related]
9. How many phenotypes for the FBXO11 related disease? Report on a new patient with a tricho-rhino-phalangeal like phenotype.
Mégarbané A; Mehawej C; Mahfoud D; Chouery E; Devriendt K; Hijazi M; Ryu SW; Kim J; McNeill A
Eur J Med Genet; 2024 Apr; 69():104944. PubMed ID: 38679370
[TBL] [Abstract][Full Text] [Related]
10. De novo missense variants in FBXO11 alter its protein expression and subcellular localization.
Gregor A; Meerbrei T; Gerstner T; Toutain A; Lynch SA; Stals K; Maxton C; Lemke JR; Bernat JA; Bombei HM; Foulds N; Hunt D; Kuechler A; Beygo J; Stöbe P; Bouman A; Palomares-Bralo M; Santos-Simarro F; Garcia-Minaur S; Pacio-Miguez M; Popp B; Vasileiou G; Hebebrand M; Reis A; Schuhmann S; Krumbiegel M; Brown NJ; Sparber P; Melikyan L; Bessonova L; Cherevatova T; Sharkov A; Shcherbakova N; Dabir T; Kini U; Schwaibold EMC; Haack TB; Bertoli M; Hoffjan S; Falb R; Shinawi M; Sticht H; Zweier C
Hum Mol Genet; 2022 Feb; 31(3):440-454. PubMed ID: 34505148
[TBL] [Abstract][Full Text] [Related]
11. Next generation sequencing reveals novel homozygous frameshift in
Naseer MI; Abdulkareem AA; Jan MM; Chaudhary AG; Alharazy S; AlQahtani MH
Saudi J Biol Sci; 2020 Nov; 27(11):3125-3131. PubMed ID: 33100873
[TBL] [Abstract][Full Text] [Related]
12. Novel variants in TNRC6B cause global developmental delay with speech and behavioral abnormalities, short stature, low body weight, café-au-lait spots, and metabolic abnormality.
Yang Q; Ou S; Zhou X; Yi S; Lin L; Yi S; Zhang S; Qin Z; Luo J
Mol Genet Genomic Med; 2024 Feb; 12(2):e2408. PubMed ID: 38404251
[TBL] [Abstract][Full Text] [Related]
13. Genetic determinants of global developmental delay and intellectual disability in Ukrainian children.
Shchubelka K; Turova L; Wolfsberger W; Kalanquin K; Williston K; Kurutsa O; Makovetska A; Hasynets Y; Mirutenko V; Vakerych M; Oleksyk TK
J Neurodev Disord; 2024 Mar; 16(1):13. PubMed ID: 38539105
[TBL] [Abstract][Full Text] [Related]
14. Novel In-Frame Deletion
Lee CG; Kim HJ; Seol CA; Ki CS
Neurol Genet; 2024 Feb; 10(1):e200116. PubMed ID: 38179413
[TBL] [Abstract][Full Text] [Related]
15. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
[TBL] [Abstract][Full Text] [Related]
16. Homozygous Missense Variant in the N-Terminal Region of ANK3 Gene Is Associated with Developmental Delay, Seizures, Speech Abnormality, and Aggressive Behavior.
Younus M; Rasheed M; Lin Z; Asiri SA; Almazni IA; Alshehri MA; Shafiq S; Iqbal I; Khan A; Ullah H; Umair M; Waqas A
Mol Syndromol; 2023 Feb; 14(1):11-20. PubMed ID: 36777705
[TBL] [Abstract][Full Text] [Related]
17. De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features.
Douglas G; Cho MT; Telegrafi A; Winter S; Carmichael J; Zackai EH; Deardorff MA; Harr M; Williams L; Psychogios A; Erwin AL; Grebe T; Retterer K; Juusola J
Am J Med Genet A; 2018 Sep; 176(9):1845-1851. PubMed ID: 30055086
[TBL] [Abstract][Full Text] [Related]
18. EMC10 homozygous variant identified in a family with global developmental delay, mild intellectual disability, and speech delay.
Umair M; Ballow M; Asiri A; Alyafee Y; Al Tuwaijri A; Alhamoudi KM; Aloraini T; Abdelhakim M; Althagafi AT; Kafkas S; Alsubaie L; Alrifai MT; Hoehndorf R; Alfares A; Alfadhel M
Clin Genet; 2020 Dec; 98(6):555-561. PubMed ID: 32869858
[TBL] [Abstract][Full Text] [Related]
19. A de novo PAK1 likely pathogenic variant and a de novo terminal 1q microdeletion in a Chinese girl with global developmental delay, severe intellectual disability, and seizures.
Zhuang J; Xie M; Yao J; Fu W; Zeng S; Jiang Y; Wang Y; Xie Y; Wang G; Chen C
BMC Med Genomics; 2023 Jan; 16(1):3. PubMed ID: 36624491
[TBL] [Abstract][Full Text] [Related]
20. Clinical use of whole exome sequencing in children with developmental delay/intellectual disability.
Jo YH; Choi SH; Yoo HW; Kwak MJ; Park KH; Kong J; Lee YJ; Nam SO; Lee BL; Chung WY; Oh SH; Kim YM
Pediatr Neonatol; 2024 Jan; ():. PubMed ID: 38281861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
